Neurosciences
ROCHESTER, Minn. — An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in[...]
Latest stories
Individualized Medicine
May 23, 2024
Clinical Trials
May 20, 2024
Clinical Trials
May 17, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community